What are the etiologies and risk factors for Serratia bacteremia?

Causes and Risk Factors for Serratia Bacteremia

Serratia bacteremia is predominantly a nosocomial infection occurring in severely ill, immunocompromised patients with indwelling medical devices, with the urinary tract being the most common source, followed by respiratory tract, intravascular catheters, and contaminated medical equipment.

Primary Sources of Infection

Urinary Tract (Most Common)

• The urinary tract is the most frequent source of Serratia marcescens bacteremia, particularly in patients with indwelling urinary catheters 1
• Serratia species are among the most common pathogens in complicated urinary tract infections 1
• Catheter-associated UTIs account for approximately 20% of hospital-acquired bacteremias 1
• The incidence of bacteriuria with indwelling catheterization is 3-8% per day, with catheter duration being the most critical risk factor 1
• In one large series, urinary infection was the most common presentation in 91% of cases 2

Respiratory Tract

• The lung represents the second most common portal of entry for Serratia bacteremia 3
• Serratia can cause nosocomial pneumonia, particularly in ventilated patients 4

Intravascular Catheters

• Central venous catheters are a major source, though Serratia is less common than staphylococci and Candida in catheter-related bloodstream infections 1
• Long-term indwelling Hickman catheters (right atrial) are particularly high-risk 5
• Microbes colonizing catheter hubs and skin surrounding insertion sites embedded in biofilm serve as infection sources 1

Gastrointestinal and Skin

• The gastrointestinal tract and skin represent less common but documented portals of entry 3
• Faecal excretion of Serratia may be a significant portal of dissemination 2

Major Risk Factors

Healthcare-Associated Factors

• 80.4% of Serratia bacteremia cases are nosocomial 3
• 48.2% of cases occur in intensive care units 3
• Presence of indwelling urinary catheters is significantly associated with mortality 6
• Device revision/replacement and amount of indwelling hardware increase infection risk 4

Immunocompromised States

• Malignancy is the most common underlying disorder, followed by renal failure (acute or chronic) and diabetes mellitus 3
• Metastatic cancer treated with chemotherapy creates multiple immune suppression factors 7
• Neutropenia predisposes to Serratia infections, particularly in patients with profound neutropenia (<100 polymorphonuclear leukocytes/mL) lasting 7-10 days 4
• Corticosteroid use and renal dysfunction increase infection risk 4

Contaminated Medical Equipment and Infusate

• Contaminated intravenous fluids and medical equipment are critical sources during outbreaks 4, 1
• Gram-negative bacilli capable of reproducing at room temperature, including Serratia species, are most often implicated in contaminated infusate 4, 1
• Contaminated aqueous chlorhexidine in bedside containers has caused documented outbreaks 5
• Any fluids administered through intravenous catheters can become contaminated during manufacturing or healthcare preparation 4

Clinical Severity Indicators

Mortality Predictors

• Lower serum albumin level is independently associated with 28-day mortality (adjusted OR 0.206) 6
• Elevated Sequential Organ Failure Assessment (SOFA) score at bacteremia onset is independently associated with mortality (adjusted OR 1.474) 6
• Overall 28-day mortality ranges from 22-25% 3, 6
• Onset of bacteremia during ICU stay is significantly associated with fatal outcomes 6

High-Risk Clinical Scenarios

• Patients with multiple indwelling devices (urinary catheters, central lines, endotracheal tubes) 3, 2
• Debilitated patients with prolonged hospitalization 2
• Patients receiving broad-spectrum antibiotics, which provide selective pressure 4
• Polysubstance abuse combined with other immunocompromising conditions 7

Antimicrobial Resistance Considerations

• Serratia can carry antibiotic-resistance plasmids, making elimination difficult once established 2
• Tigecycline lacks in vitro activity against Serratia species and should not be used 4
• Multiple antibiotic resistance is common, including aminoglycosides 5
• 20% of strains may be fully resistant to all routinely tested agents 2
• Plasmid-mediated metallo-β-lactamases can spread among Serratia and other gram-negative pathogens 4

Common Pitfalls

• Do not dismiss Serratia isolation as contamination—it is an established opportunistic pathogen requiring treatment in symptomatic patients 2
• Recognize that Serratia bacteremia often indicates cross-infection from a hospital reservoir of resistant organisms 2
• Be aware that contaminated medical equipment may not be immediately obvious and requires thorough investigation during outbreaks 4, 5
• Lower serum C-reactive protein levels paradoxically correlate with mortality, likely reflecting inability to mount inflammatory response 6